• Users Online: 165
  • Print this page
  • Email this page
Year : 2019  |  Volume : 6  |  Issue : 4  |  Page : 193-196

Allogeneic hematopoietic stem cell transplantation in a 76-year-old woman with relapsed acute myeloid leukemia

Division of Hematology and Medical Oncology, Far Eastern Memorial Hospital, New Taipei City, Taiwan

Correspondence Address:
Dr. Pei-Ying Hsieh
Division of Hematology and Medical Oncology, Far Eastern Memorial Hospital, No. 21, Sec. 2, Nanya S. Road, Banciao Dist., New Taipei City 220
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JCRP.JCRP_15_19

Rights and Permissions

Acute myeloid leukemia (AML) is commonly diagnosed in the elderly. Treatment of AML frequently requires hematopoietic stem cell transplantation (HSCT), which is associated with significant treatment-related toxicity and is considered to be too intense for older patients. However, with the development of reduced intensity conditioning, patients of increasing age are now considered for HSCT. We present a case of relapsed AML in a 76-year-old woman who was successfully treated with allogeneic stem cell transplantation. She endured the process without significant complications and achieved a durable treatment response, demonstrating the feasibility of allogeneic HSCT in patients with very advanced age.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded72    
    Comments [Add]    

Recommend this journal